Erratum to: Eur Radiol

DOI 10.1007/s00330-016-4437-9

Unfortunately, there is a mistake in the section Results, Clinical safety. While the text states that “no severe AEs were reported”, in fact one severe AE was reported in the iomeprol group (one severe injection site pain assessed as possibly related to contrast agent), as shown in Table 5.

In addition, the name of the author Jean-François Paul was rendered incorrectly in the original publication but has since been corrected.

The authors apologize for these mistakes.